Stock SCL STEPAN COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Stepan Company

Equities

SCL

US8585861003

Specialty Chemicals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-17 pm EDT 		5-day change 1st Jan Change
88.06 USD +0.46% Intraday chart for Stepan Company -1.11% -6.86%
Apr. 30 Transcript : Stepan Company, Q1 2024 Earnings Call, Apr 30, 2024
Apr. 30 Earnings Flash (SCL) STEPAN COMPANY Reports Q1 Revenue $551.4M MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,305 2,680 2,786 2,366 2,115 1,979 - -
Enterprise Value (EV) 1 2,305 2,680 2,990 2,366 2,115 1,979 1,979 1,979
P/E ratio - - 21 x 16.7 x 54 x 32.4 x 18.7 x -
Yield 1.01% 0.95% 1.01% 1.29% 1.55% 1.73% 1.83% -
Capitalization / Revenue 1.24 x 1.43 x 1.19 x 0.85 x 0.91 x 0.86 x 0.78 x -
EV / Revenue 1.24 x 1.43 x 1.19 x 0.85 x 0.91 x 0.86 x 0.78 x -
EV / EBITDA 10.1 x 10.4 x 10.4 x 7.84 x 11.7 x 8.23 x 6.48 x -
EV / FCF - - -25.6 x -21.5 x -24.7 x 10.7 x 10.7 x 10.2 x
FCF Yield - - -3.91% -4.65% -4.04% 9.31% 9.32% 9.83%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 22,505 22,461 22,416 22,228 22,367 22,475 - -
Reference price 2 102.4 119.3 124.3 106.5 94.55 88.06 88.06 88.06
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,859 1,870 2,346 2,773 2,326 2,303 2,545 -
EBITDA 1 227.5 258.3 269.2 302 180 240.6 305.6 -
EBIT 1 148.8 178.4 178.3 207.3 58.61 111.6 173.1 208.7
Operating Margin 8% 9.54% 7.6% 7.48% 2.52% 4.85% 6.8% -
Earnings before Tax (EBT) 1 - - 172.5 188.7 48.39 93.3 154.6 -
Net income 1 - - 137.8 147.2 40.2 60.75 102.5 -
Net margin - - 5.87% 5.31% 1.73% 2.64% 4.03% -
EPS 2 - - 5.920 6.380 1.750 2.720 4.720 -
Free Cash Flow 1 - - -109 -110.1 -85.46 184.2 184.5 194.6
FCF margin - - -4.65% -3.97% -3.67% 8% 7.25% -
FCF Conversion (EBITDA) - - - - - 76.56% 60.38% -
FCF Conversion (Net income) - - - - - 303.21% 180% -
Dividend per Share 2 1.030 1.130 1.250 1.370 1.470 1.525 1.610 -
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 610 675.3 751.6 719.2 627.2 651.4 580 562.2 532.1 551.4 571.5 596.5 583.4 635.4 636.2
EBITDA 1 46.22 86.26 101 78.36 36.38 48.7 45.8 45.82 37.5 51.2 56.82 70.02 62.92 74.47 78.53
EBIT 1 27.23 63.35 77.64 54.66 11.69 21.06 17.81 19.52 0.23 20.17 26.5 38.47 26.2 39.45 41.45
Operating Margin 4.46% 9.38% 10.33% 7.6% 1.86% 3.23% 3.07% 3.47% 0.04% 3.66% 4.64% 6.45% 4.49% 6.21% 6.51%
Earnings before Tax (EBT) 1 22.24 59.39 69.54 50.46 9.311 19.9 16.31 15.84 -3.666 19.46 19.75 33.7 20.4 34.5 36.55
Net income 1 17 44.81 52.13 39.38 10.83 16.14 12.68 12.57 -1.193 13.89 12.5 21.4 12.95 22.8 24.25
Net margin 2.79% 6.64% 6.94% 5.48% 1.73% 2.48% 2.19% 2.24% -0.22% 2.52% 2.19% 3.59% 2.22% 3.59% 3.81%
EPS 2 0.7300 1.930 2.260 1.710 0.4700 0.7000 0.5500 0.5500 -0.0500 0.6100 0.6500 0.9800 0.4800 0.8700 1.110
Dividend per Share 2 0.3350 0.3350 0.3350 0.3350 0.3650 0.3650 0.3650 - 0.3750 - 0.3775 0.3775 0.3975 0.4050 0.4050
Announcement Date 2/17/22 4/26/22 7/27/22 10/19/22 2/16/23 4/25/23 7/26/23 10/18/23 2/20/24 4/30/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - 204 - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - 0.7594 x - - - - -
Free Cash Flow 1 - - -109 -110 -85.5 184 185 195
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 106 126 194 302 260 126 120 115
Capex / Sales 5.68% 6.73% 8.29% 10.87% 11.19% 5.49% 4.72% -
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/20/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Stepan Company

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
88.06 USD
Average target price
102 USD
Spread / Average Target
+15.83%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
STEPAN COMPANY Stock Stepan Company
-6.86% 1.98B
ECOLAB INC. Stock Ecolab Inc.
+17.80% 66.73B
SIKA AG Stock Sika AG
+2.92% 49.79B
GIVAUDAN SA Stock Givaudan SA
+19.98% 42.5B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+20.88% 26.45B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+12.04% 19.66B
CELANESE CORPORATION Stock Celanese Corporation
+1.27% 17.18B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-22.98% 15.82B
SYMRISE AG Stock Symrise AG
+2.77% 15.56B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-9.25% 15.41B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. SCL Stock
  4. Financials Stepan Company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW